Step I Octreotide

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

aspiringmd1015

Full Member
7+ Year Member
Advertisement - Members don't see this ad
used in variceal bleeding to reduce portal venous pressure as we all know, but FA 2015 says on pg 379 that it inhibits the actions of splanchnic vasoconstriction hormones, while kaplan q bank says the opposite, inhibits splanchnic vasodilatory hormtones thus decreasing portal inflow and helping to decrease variceal bleeding, so which one is it? to cause vasoconstriction wouldnt that also increase the hydrostatic pressure? confused, help!
 
used in variceal bleeding to reduce portal venous pressure as we all know, but FA 2015 says on pg 379 that it inhibits the actions of splanchnic vasoconstriction hormones, while kaplan q bank says the opposite, inhibits splanchnic vasodilatory hormtones thus decreasing portal inflow and helping to decrease variceal bleeding, so which one is it? to cause vasoconstriction wouldnt that also increase the hydrostatic pressure? confused, help!

Already in the FA errata.